• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

A one-step DGGE scanning method for detection of mutations in the K-, N-, and H-ras oncogenes: mutations at codons 12, 13 and 61 are rare in B-cell non-Hodgkin's lymphoma.

作者信息

Nedergaard T, Guldberg P, Ralfkiaer E, Zeuthen J

机构信息

Department of Tumor Cell Biology, Danish Cancer Society, Copenhagen.

出版信息

Int J Cancer. 1997 May 2;71(3):364-9. doi: 10.1002/(sici)1097-0215(19970502)71:3<364::aid-ijc10>3.0.co;2-g.

DOI:10.1002/(sici)1097-0215(19970502)71:3<364::aid-ijc10>3.0.co;2-g
PMID:9139869
Abstract

Mutations in the N-, K-, and H-ras genes are key events in the process of carcinogenesis of many human cancers and may serve as important targets for therapeutic intervention. We developed a simple diagnostic method that in one step and within 5 hr determines the mutational status of any of the 3 ras genes in a given tumor sample. The method combines polymerase chain reaction (PCR) with denaturing gradient gel electrophoresis (DGGE) and allows simultaneous mutation scanning of 6 regions covering "hot-spot" codons 12, 13 and 61 of the 3 ras genes. The sensitivity of the assay was demonstrated by the analysis of control mutations, either naturally occurring or created by site-directed mutagenesis. We further demonstrate that unambiguous identification of ras mutations can be achieved by heteroduplex analysis in denaturing gradient gels, circumventing sequence analysis. We applied the method to establish the mutational status of all 3 ras genes in 123 samples of B-cell non-Hodgkin's lymphoma. Altogether, one diffuse large B-cell lymphoma and one B-cell chronic lymphocytic leukemia (B-CLL) harbored a mutation (G12S and G12A, respectively) in the K-ras gene, and one B-CLL harbored a mutation (Q61R) in the N-ras gene. We therefore conclude that ras mutations only contribute rarely, if at all, to carcinogenesis in B-cell non-Hodgkin's lymphoma.

摘要

相似文献

1
A one-step DGGE scanning method for detection of mutations in the K-, N-, and H-ras oncogenes: mutations at codons 12, 13 and 61 are rare in B-cell non-Hodgkin's lymphoma.
Int J Cancer. 1997 May 2;71(3):364-9. doi: 10.1002/(sici)1097-0215(19970502)71:3<364::aid-ijc10>3.0.co;2-g.
2
Denaturing gradient gel electrophoresis (DGGE) assay for K-ras and N-ras genes: detection of K-ras point mutations in human lung tumour DNA.K-ras和N-ras基因的变性梯度凝胶电泳(DGGE)分析:检测人肺肿瘤DNA中的K-ras点突变。
Hum Mol Genet. 1993 Jun;2(6):639-44. doi: 10.1093/hmg/2.6.639.
3
De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct.原发性CD5阳性和里氏综合征相关的弥漫性大B细胞淋巴瘤在基因分型上是不同的。
Am J Pathol. 1995 Jul;147(1):207-16.
4
Mutations of p53, c-kit, K-ras, and beta-catenin gene in non-Hodgkin's lymphoma of adrenal gland.肾上腺非霍奇金淋巴瘤中p53、c-kit、K-ras和β-连环蛋白基因的突变
Jpn J Cancer Res. 2002 Mar;93(3):267-74. doi: 10.1111/j.1349-7006.2002.tb02168.x.
5
The pattern of mutational involvement of RAS genes in human hematologic malignancies determined by DNA amplification and direct sequencing.
Blood. 1990 Apr 15;75(8):1684-90.
6
Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung.肺鳞状细胞癌中K-ras癌基因的突变及H-ras突变的缺失
Clin Cancer Res. 1995 Mar;1(3):359-65.
7
Detection of K-ras mutations in stools of patients with colorectal cancer by mutant-enriched PCR.通过突变富集PCR检测结直肠癌患者粪便中的K-ras突变
Int J Cancer. 1996 May 3;66(3):332-6. doi: 10.1002/(SICI)1097-0215(19960503)66:3<332::AID-IJC11>3.0.CO;2-D.
8
K-ras codon 12 mutations in biliary tract tumors detected by polymerase chain reaction denaturing gradient gel electrophoresis.通过聚合酶链反应-变性梯度凝胶电泳检测胆道肿瘤中的K-ras密码子12突变。
Cancer. 1994 Jun 1;73(11):2727-33. doi: 10.1002/1097-0142(19940601)73:11<2727::aid-cncr2820731113>3.0.co;2-#.
9
Separation of transforming N-ras mutations in codons 12, 13 and 61 by denaturing gradient gel electrophoresis: investigation based on a set of phagemid constructs.
Mutat Res. 1993 Feb;285(2):287-94. doi: 10.1016/0027-5107(93)90117-x.
10
Analysis of RAS oncogene mutations in human lymphoid malignancies.人类淋巴恶性肿瘤中RAS癌基因突变的分析
Proc Natl Acad Sci U S A. 1988 Dec;85(23):9268-72. doi: 10.1073/pnas.85.23.9268.

引用本文的文献

1
KRAS and RAS-MAPK Pathway Deregulation in Mature B Cell Lymphoproliferative Disorders.成熟B细胞淋巴增殖性疾病中的KRAS与RAS-MAPK信号通路失调
Cancers (Basel). 2022 Jan 28;14(3):666. doi: 10.3390/cancers14030666.
2
Concurrent Diagnosis of Chronic Myeloid Leukemia and Follicular Lymphoma: An Unreported Presentation.慢性髓系白血病与滤泡性淋巴瘤的同时诊断:一种未报道的表现形式
Case Rep Hematol. 2018 Sep 9;2018:7493601. doi: 10.1155/2018/7493601. eCollection 2018.
3
Size-based enrichment of exfoliated tumor cells in urine increases the sensitivity for DNA-based detection of bladder cancer.
基于大小对尿液中脱落肿瘤细胞进行富集可提高基于DNA检测膀胱癌的灵敏度。
PLoS One. 2014 Apr 14;9(4):e94023. doi: 10.1371/journal.pone.0094023. eCollection 2014.
4
New mutations in chronic lymphocytic leukemia identified by target enrichment and deep sequencing.通过靶向富集和深度测序鉴定慢性淋巴细胞白血病的新突变。
PLoS One. 2012;7(6):e38158. doi: 10.1371/journal.pone.0038158. Epub 2012 Jun 1.
5
Oncogenic RAS mutations in myeloma cells selectively induce cox-2 expression, which participates in enhanced adhesion to fibronectin and chemoresistance.骨髓瘤细胞中的致癌RAS突变选择性诱导环氧合酶-2(COX-2)表达,其参与增强对纤连蛋白的黏附及化疗耐药。
Blood. 2006 Jun 1;107(11):4484-90. doi: 10.1182/blood-2005-09-3926. Epub 2006 Feb 23.
6
Conditional expression of oncogenic K-ras from its endogenous promoter induces a myeloproliferative disease.致癌性K-ras从其内源启动子的条件性表达会诱发骨髓增殖性疾病。
J Clin Invest. 2004 Feb;113(4):528-38. doi: 10.1172/JCI20476.
7
Mutations of p53, c-kit, K-ras, and beta-catenin gene in non-Hodgkin's lymphoma of adrenal gland.肾上腺非霍奇金淋巴瘤中p53、c-kit、K-ras和β-连环蛋白基因的突变
Jpn J Cancer Res. 2002 Mar;93(3):267-74. doi: 10.1111/j.1349-7006.2002.tb02168.x.